Home › Calculator › LMLLF Dividend Calculator 2026
LMLLF Dividend DRIP Calculator 2026
37313.43% YieldHealthcarePharmadrug Inc. · OTC
Price: $0.01 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When LMLLF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your LMLLF snowball 📈
$10,000 in LMLLF → $1.8457127729435916e+37M in 10 years · $1,538,089,951,983,197,000,000,000,000,000,000,000,000,000.00/month
About Pharmadrug Inc. (LMLLF) — Dividend Analysis 2026
Pharmadrug Inc. operates as a specialized pharmaceutical company, primarily dedicated to the exploration, development, and commercialization of controlled substances and naturally derived therapeutic agents. Its portfolio encompasses novel compounds like psychedelics and cannabis, alongside other naturally sourced approved medicines. Beyond its core research and development activities, the firm plays a crucial role in importing and distributing medical cannabis to pharmacies across Germany and the broader European Union. The company also oversees Super Smart, an initiative focused on promoting and exploring the benefits of functional and psilocybin mushrooms. Additionally, Pharmadrug actively engages in researching and enhancing established natural remedies. Significant research collaborations underpin its innovative pipeline, including an agreement with the University of Michigan to assess N, N-dimethyltryptamine's (DMT) role in various conscious states. Another partnership with the Southwest Research Institute is geared towards the non-clinical and clinical manufacturing of cepharanthine. Furthermore, a clinical trial agreement with Johns Hopkins University facilitates a study comparing the acute and enduring psychological and neural effects of DMT against an undisclosed, highly active comparator molecule. Headquartered in Toronto, Canada, the company adopted its current name, Pharmadrug Inc., in October 2019, having previously operated as Aura Health Inc.
Compare LMLLF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full LMLLF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LMLLF position with:
🌍 LMLLF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold LMLLF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 37313.43% | 37310.63% | $3,731,343 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 31716.42% | 31713.62% | $3,171,642 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 29850.74% | 29847.94% | $2,985,074 / yr |
| 🇬🇧 UK ISA | 0% | 37313.43% | 37310.63% | $3,731,343 / yr |
| 🇬🇧 UK Taxable | 8.75% | 34048.50% | 34045.70% | $3,404,850 / yr |
| 🇨🇦 TFSA | 0% | 37313.43% | 37310.63% | $3,731,343 / yr |
| 🇨🇦 CA Taxable | 25% | 27985.07% | 27982.27% | $2,798,507 / yr |
| 🇦🇺 Super (pension) | 15% | 31716.42% | 31713.62% | $3,171,642 / yr |
| 🇦🇺 AU Taxable | 30% | 26119.40% | 26116.60% | $2,611,940 / yr |
| 🇩🇪 DE Taxable | 26.375% | 27472.01% | 27469.21% | $2,747,201 / yr |
| 🇫🇷 FR Taxable | 30% | 26119.40% | 26116.60% | $2,611,940 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 LMLLF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 LMLLF Dividend Payment Schedule
LMLLF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 LMLLF vs Healthcare Benchmarks
How LMLLF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LMLLF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ LMLLF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LMLLF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Pharmadrug Inc. (LMLLF) is currently trading at $0.01, 99% below its 52-week high. The current dividend yield is 37313.43% based on an annual payout of $2.00 per share.
LMLLF (Pharmadrug Inc.) — 37313.43% Dividend Yield Analysis
Pharmadrug Inc. (LMLLF) is a healthcare stock currently trading at $0.01 with a dividend yield of 37313.43%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (37313.43%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.